Impact of maternal glycemic control during pregnancy on early biomarkers of neonatal metabolic syndrome - Takeaways - MDSpire

Impact of maternal glycemic control during pregnancy on early biomarkers of neonatal metabolic syndrome

  • By

  • Xiaogang An

  • Yajun Kong

  • June 25, 2026

  • 0 min

Share

  • 1

    The study enrolled 130 pregnant women to assess the impact of maternal glycemic control on neonatal metabolic syndrome biomarkers.

  • 2

    Neonates from the poor glycemic control group showed lower levels of tyrosine and alanine, and higher levels of total carnitine, C18 acylcarnitine, and bilirubin.

  • 3

    The incidence of neonatal hypoglycemia was significantly higher in the poor glycemic control group compared to the adequate control group.

  • 4

    After adjusting for confounders, poor maternal glycemic control was linked to decreased neonatal tyrosine and alanine, and increased total carnitine and bilirubin.

  • 5

    The findings suggest that optimizing maternal glycemic control may help mitigate early metabolic disturbances in neonates.

Original Source(s)

Impact of maternal glycemic control during pregnancy on early biomarkers of neonatal metabolic syndrome

  • by Xiaogang An, Yajun Kong

  • June 25, 2026

Related Content

Fumarate hydratase-deficient uterine leiomyoma: A rare case report and literature review

Evidence summary of best practices for prevention and management of postpartum hemorrhage in obstetric clinical practice

Beta-2 Agonists Tied to ASD Risk?

Systematic review of 8 observational studies found limited evidence on associations between prenatal asthma-medication exposure and neurodevelopmental outcomes, with autism spectrum disorder the only outcome suitable for meta-analysis.